Acrivon Therapeutics

ACRVNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$74.047 M

$1.73 +2.37%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$77.9M

Loss-making

Shares outstanding

38,744,446

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#322Adicet BioACET$74.7M
#323TalpheraTLPH$74.2M
#324Acrivon TherapeuticsACRV$74.0M
#325Elicio TherapeuticsELTX$73.4M
#326Cypherpunk TechnologiesCYPH$73.3M

Where these numbers come from

Share counts and financials for Acrivon Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.